Dextromethorphan hydrobromide 20 mg / guaifenesin 200 mg / pseudoephedrine hydrochloride 30 mg per 5 mL Oral Suspension
RxNorm 1362206
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1362206 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dextromethorphan hydrobromide 20 mg / guaifenesin 200 mg / pseudoephedrine hydrochloride 30 mg per 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Dextromethorphan hydrobromide 4 mg/ML / guaifenesin 40 mg/ML / pseudoephedrine hydrochloride 6 mg/ML Oral Suspension
(Atom ID: 12347051)
SY
Synonym (SY):
Dextromethorphan hydrobromide 20 mg / guaifenesin 200 mg / pseudoephedrine hydrochloride 30 mg per 5 mL Oral Suspension
(Atom ID: 5038394)
TMSY
Tall Man Lettering Synonym (TMSY):
Dextromethorphan hydrobromide 20 mg / guaiFENesin 200 mg / pseudoephedrine hydrochloride 30 mg per 5 mL Oral Suspension
(Atom ID: 5038468)
TMSY
Tall Man Lettering Synonym (TMSY):
Dextromethorphan hydrobromide 4 mg/ML / guaiFENesin 40 mg/ML / pseudoephedrine hydrochloride 6 mg/ML Oral Suspension
(Atom ID: 12376871)
SY
Synonym (SY):
Dextromethorphan hydrobromide 40 mg / guaifenesin 400 mg / pseudoephedrine hydrochloride 60 mg per 10 mL Oral Suspension
(Atom ID: 5038395)
TMSY